{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["10"],"submitter":["Shifman O"],"pubmed_abstract":["Great efforts are being made to develop new rapid antibiotic susceptibility tests to meet the demand for clinical relevance versus disease progression. This is important especially in diseases caused by bacteria such as <i>Yersinia pestis</i>, the causative agent of plague, which grows rapidly <i>in vivo</i> but relatively slow <i>in vitro</i>. This compromises the ability to use standard growth-based susceptibility tests to obtain rapid and proper antibiotic treatment guidance. Using our previously described platform of quantifying antibiotic-specific transcriptional changes, we developed a molecular test based on changes in expression levels of doxycycline response-dependent marker genes that we identified by transcriptomic analysis. This enabled us to determine the minimal inhibitory co"],"journal":["Frontiers in microbiology"],"pagination":["754"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6477067"],"repository":["biostudies-literature"],"pubmed_title":["A Rapid Antimicrobial Susceptibility Test for Determining <i>Yersinia pestis</i> Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers."],"pmcid":["PMC6477067"],"pubmed_authors":["Steinberger-Levy I","Ber R","Shifman O","Mamroud E","Gur D","Rotem S","Aloni-Grinstein R","Ron I","Aftalion M"],"additional_accession":[]},"is_claimable":false,"name":"A Rapid Antimicrobial Susceptibility Test for Determining <i>Yersinia pestis</i> Susceptibility to Doxycycline by RT-PCR Quantification of RNA Markers.","description":"Great efforts are being made to develop new rapid antibiotic susceptibility tests to meet the demand for clinical relevance versus disease progression. This is important especially in diseases caused by bacteria such as <i>Yersinia pestis</i>, the causative agent of plague, which grows rapidly <i>in vivo</i> but relatively slow <i>in vitro</i>. This compromises the ability to use standard growth-based susceptibility tests to obtain rapid and proper antibiotic treatment guidance. Using our previously described platform of quantifying antibiotic-specific transcriptional changes, we developed a molecular test based on changes in expression levels of doxycycline response-dependent marker genes that we identified by transcriptomic analysis. This enabled us to determine the minimal inhibitory co","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019","modification":"2026-05-04T14:28:12.024Z","creation":"2019-06-06T23:07:11Z"},"accession":"S-EPMC6477067","cross_references":{"pubmed":["31040834"],"doi":["10.3389/fmicb.2019.00754"]}}